178 related articles for article (PubMed ID: 25452172)
1. (-)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein.
Hu Q; Chang X; Yan R; Rong C; Yang C; Cheng S; Gu X; Yao H; Hou X; Mo Y; Zhao L; Chen Y; Dinlin X; Wang Q; Fang S
Med Oncol; 2015 Jan; 32(1):390. PubMed ID: 25452172
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
3. EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation.
Li M; Li JJ; Gu QH; An J; Cao LM; Yang HP; Hu CP
Oncol Rep; 2016 Apr; 35(4):2339-47. PubMed ID: 26794417
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
Nihal M; Ahmad N; Mukhtar H; Wood GS
Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
[TBL] [Abstract][Full Text] [Related]
5. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate reduces tubular cell apoptosis in mice with ureteral obstruction.
Wang Y; Liu N; Bian X; Sun G; Du F; Wang B; Su X; Li D
J Surg Res; 2015 Jul; 197(1):145-54. PubMed ID: 25913488
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'; Shin DM
Int J Cancer; 2008 Sep; 123(5):1005-14. PubMed ID: 18546267
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway.
Liu G; He L
Pharmacology; 2019; 103(5-6):303-314. PubMed ID: 30840953
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway.
Yang WH; Fong YC; Lee CY; Jin TR; Tzen JT; Li TM; Tang CH
J Cell Biochem; 2011 Jun; 112(6):1601-11. PubMed ID: 21328612
[TBL] [Abstract][Full Text] [Related]
12. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.
Lee JH; Jeong YJ; Lee SW; Kim D; Oh SJ; Lim HS; Oh HK; Kim SH; Kim WJ; Jung JY
Cancer Lett; 2010 Apr; 290(1):68-75. PubMed ID: 19781850
[TBL] [Abstract][Full Text] [Related]
13. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation.
Roy AM; Baliga MS; Katiyar SK
Mol Cancer Ther; 2005 Jan; 4(1):81-90. PubMed ID: 15657356
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
16. The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
Yang L; Zhang W; Chopra S; Kaur D; Wang H; Li M; Chen P; Zhang W
Curr Drug Targets; 2020; 21(11):1099-1104. PubMed ID: 32364072
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway.
Ran ZH; Xu Q; Tong JL; Xiao SD
World J Gastroenterol; 2007 Aug; 13(31):4255-9. PubMed ID: 17696257
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells.
Tang GQ; Yan TQ; Guo W; Ren TT; Peng CL; Zhao H; Lu XC; Zhao FL; Han X
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1179-85. PubMed ID: 20127255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
